These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20527046)

  • 1. Prolonged survival and improved glycemia in BioBreeding diabetic rats after early sustained exposure to glucagon-like peptide 1.
    Yanay O; Moralejo D; Kernan K; Brzezinski M; Fuller JM; Barton RW; Lernmark A; Osborne WR
    J Gene Med; 2010 Jun; 12(6):538-44. PubMed ID: 20527046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained glucagon-like peptide 1 expression from encapsulated transduced cells to treat obese diabetic rats.
    Moralejo D; Yanay O; Kernan K; Bailey A; Lernmark A; Osborne W
    J Biosci Bioeng; 2011 Apr; 111(4):383-7. PubMed ID: 21216666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats.
    Valverde I; Wang GS; Burghardt K; Kauri LM; Redondo A; Acitores A; Villanueva-Peñacarrillo ML; Courtois P; Sener A; Cancelas J; Malaisse WJ; Scott FW
    Endocrine; 2004 Feb; 23(1):77-84. PubMed ID: 15034199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose control and long-term survival in biobreeding/Worcester rats after intraperitoneal implantation of hydrophilic macrobeads containing porcine islets without immunosuppression.
    Jain K; Asina S; Yang H; Blount ED; Smith BH; Diehl CH; Rubin AL
    Transplantation; 1999 Dec; 68(11):1693-700. PubMed ID: 10609945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice.
    Wei R; Cui X; Feng J; Gu L; Lang S; Wei T; Yang J; Liu J; Le Y; Wang H; Yang K; Hong T
    Metabolism; 2020 Oct; 111():154324. PubMed ID: 32712220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age.
    Tourrel C; Bailbé D; Meile MJ; Kergoat M; Portha B
    Diabetes; 2001 Jul; 50(7):1562-70. PubMed ID: 11423477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excessive islet NO generation in type 2 diabetic GK rats coincides with abnormal hormone secretion and is counteracted by GLP-1.
    Salehi A; Meidute Abaraviciene S; Jimenez-Feltstrom J; Ostenson CG; Efendic S; Lundquist I
    PLoS One; 2008 May; 3(5):e2165. PubMed ID: 18478125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipeptidyl peptidase IV inhibitor treatment stimulates beta-cell survival and islet neogenesis in streptozotocin-induced diabetic rats.
    Pospisilik JA; Martin J; Doty T; Ehses JA; Pamir N; Lynn FC; Piteau S; Demuth HU; McIntosh CH; Pederson RA
    Diabetes; 2003 Mar; 52(3):741-50. PubMed ID: 12606516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats.
    Medina A; Parween S; Ullsten S; Vishnu N; Siu YT; Quach M; Bennet H; Balhuizen A; Åkesson L; Wierup N; Carlsson PO; Ahlgren U; Lernmark Å; Fex M
    Diabetologia; 2018 Apr; 61(4):896-905. PubMed ID: 29209740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLP-1 effect upon the GPI/IPG system in adipocytes and hepatocytes from diabetic rats.
    Márquez L; González N; Puente J; Valverde L; Villanueva-Peñacarrillo ML
    Diabetes Nutr Metab; 2001 Oct; 14(5):239-44. PubMed ID: 11806463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide 1 content of intestinal tract in adult rats injected with streptozotocin either during neonatal period or 7 d before sacrifice.
    Cancelas J; Sancho V; Villanueva-Peñacarrillo ML; Courtois P; Scott FW; Valverde I; Malaisse WJ
    Endocrine; 2002 Dec; 19(3):279-86. PubMed ID: 12624427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual β-cell function.
    Kielgast U; Holst JJ; Madsbad S
    Diabetes; 2011 May; 60(5):1599-607. PubMed ID: 21441444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin secretion and islet endocrine cell content at onset and during the early stages of diabetes in the BB rat: effect of the level of glycemic control.
    Pederson RA; Curtis SB; Chisholm CB; Gaba NR; Campos RV; Brown JC
    Can J Physiol Pharmacol; 1991 Aug; 69(8):1230-6. PubMed ID: 1782606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas.
    Suzuki S; Kawai K; Ohashi S; Mukai H; Murayama Y; Yamashita K
    Diabetes; 1990 Nov; 39(11):1320-5. PubMed ID: 2146178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
    Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
    Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of glucagon-like peptide-1 in the management of diabetes mellitus: cellular and molecular mechanisms.
    Lotfy M; Singh J; Rashed H; Tariq S; Zilahi E; Adeghate E
    Cell Tissue Res; 2014 Nov; 358(2):343-58. PubMed ID: 25115772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats.
    Perfetti R; Zhou J; Doyle ME; Egan JM
    Endocrinology; 2000 Dec; 141(12):4600-5. PubMed ID: 11108273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of diabetic rats with encapsulated islets.
    Sweet IR; Yanay O; Waldron L; Gilbert M; Fuller JM; Tupling T; Lernmark A; Osborne WR
    J Cell Mol Med; 2008 Dec; 12(6B):2644-50. PubMed ID: 18373735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans.
    Quddusi S; Vahl TP; Hanson K; Prigeon RL; D'Alessio DA
    Diabetes Care; 2003 Mar; 26(3):791-8. PubMed ID: 12610039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.